Cavernous haemangiomas, epilepsy and treatment strategies

Acta Neurologica Scandinavica

Volumn 110, Issue 6, 2004, Pages 393-397

  Stefan, H ^a,b   Hammen, T ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cavernous haemangiomas; Cerebral cavernous malformations; Epilepsy; Epilepsy surgery; Lesionectomy; Magnetencephalography; Therapeutic strategies

Indexed keywords

ARTICLE; BRAIN ELECTROPHYSIOLOGY; CAVERNOUS HEMANGIOMA; EPILEPSY; EPILEPTIC FOCUS; HUMAN; INTRACTABLE EPILEPSY; MAGNETOENCEPHALOGRAPHY; MICROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SEIZURE; SENSITIVITY AND SPECIFICITY;

EPILEPSY; HEMANGIOMA, CAVERNOUS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETOENCEPHALOGRAPHY; MICROSURGERY; NEUROSURGICAL PROCEDURES; PATIENT CARE PLANNING; POSITRON-EMISSION TOMOGRAPHY;

EID: 8844265288     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2004.00333.x     Document Type: Article

References (49)

1. ZABRAMSKI JM, WASCHER TM, SPETZLER RF et al. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 1994;80:422-32.
2. KATTAPONG VJ, HART BL, DAVIS LE. Familial cerebral cavernous angiomas: clinical and radiologic studies. Neurology 1995;45:492-7.
3. MASSA-MICON B, LUPARELLO V, BERGUI M, PAGNI CA. De novo cavernoma case report and review of literature. Surg Neurol 2000;53:484-7.
4. VAQUERO J, SALAZAR J, MARTINEZ R, MARTINEZ P, BRAVO G. Cavernomas of the central nervous system: clinical syndromes, CT scan diagnosis, and prognosis after surgical treatment in 25 cases. Acta Neurochir (Wien) 1987;85:29-33.
5. BRUNEREAU L, LABAUGE P, TOURNIER-LASSERVE E, LABERGE S, LEVY C, HOUTTEVILLE JP. Familial form of intracranial cavernous angioma: MR imaging findings in 51 families. French Society of Neurosurgery. Radiology 2000;214:209-16.
6. MORAN NF, FISH DR, KITCHEN N, SHORVON S, KENDALL BE, STEVENS JM. Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series. J Neurol Neurosurg Psychiatry 1999;66:561-8.
7. KLESIT-WELCH GUERRA WPJ, GAAB MR. Neurovaskuläre Erkrankungen: Klinik und Therapie zerebraler Kavernome. Neurovaskuläre Erkrankungen: Klinik und Therapie zerebraler Kavernome. Dt.Ärzteblatt 2001;98:1690-6.
8. WE M. The pathology of vascular (arteriovenous) malformations. J Neurosurg 1966;24:807-16.
9. AIBA T, TANAKA R, KOIKE T, KAMEYAMA S, TAKEDA N, KOMATA T. Natural history of intracranial cavernous malformations. J Neurosurg 1995;83:56-9.
10. RIGAMONTI D, HADLEY MN, DRAYER BP et al. Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med 1988;319:343-7.
11. ROBINSON JR, AWAD IA, LITTLE JR. Natural history of the cavernous angioma. J Neurosurg 1991;75:709-14.
12. OTTEN P, PIZZOLATO GP, RILLIET B, BERNEY J. 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies. Neurochirurgie 1989;35:82-3. 128-31.
13. COHEN DS, ZUBAY GP, GOODMAN RR. Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg 1995;83:237-42.
14. DELCURLING O JR, KELLY DL JR, ELSTER AD, CRAVEN TE. An analysis of the natural history of cavernous angiomas. J Neurosurg 1991;75:702-8.
15. DI TULLI JR MVSW. Hemangioma calcificans. Case report of an intraparenchymatous calcified vascular hematoma with epileptogenic potential. J Neurosurg 1979;50:110-4.
16. GIOMBINI S, MORELLO G. Cavernous angiomas of the brain. Account of fourteen personal cases and review of the literature. Acta Neurochir (Wien) 1978;40:61-82.
17. ROBINSON JR, AWAD IA, MAGDINEC M, PARANANDI L. Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery 1993;32:730-5; discussion 735-6.
18. SIEGEL AM, ROBERTS DW, HARBAUGH RE, WILLIAMSON PD. Pure lesionectomy versus tailored epilepsy surgery in treatment of cavernous malformations presenting with epilepsy. Neurosurg Rev 2000;23:80-3.
19. VOIGT K, YASARGIL MG. Cerebral cavernous haemangiomas or cavernomas. Incidence, pathology, localization, diagnosis, clinical features and treatment. Review of the literature and report of an unusual case. Neurochirurgia (Stuttg) 1976;19:59-68.
20. KUZNIECKY R, DE LA SAYETTE V, ETHIER R et al. Magnetic resonance imaging in temporal lobe epilepsy: Pathological correlations. Ann Neurol 1987;22:341-7.
21. CONVERS P, BIERME T, RYVLIN P et al. Contribution of magnetic resonance imaging in 100 cases of refractory partial epilepsy with normal CT scans. Rev Neurol (Paris) 1990;146:330-7.
22. SATOH H, MATSUI K. Electrical and mechanical modulations by oxygen-derived free-radical generating systems in guinea-pig heart muscles. J Pharm Pharmacol 1997;49:505-10.
23. KRAEMER DL, AWAD IA. Vascular malformations and epilepsy: clinical considerations and basic mechanisms. Epilepsia 1994;35(Suppl. 6):S30-43.
24. VOLTERRA A, TROTTI D, TROMBA C, FLORIDI S, RACAGNI G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosci 1994;14:2924-32.
25. CASCINO GD, JACK CR JR, PARISI JE et al. Operative strategy in patients with MRI-identified dual pathology and temporal lobe epilepsy. Epilepsy Res 1993;14:175-82.
26. STEFAN H, HUMMEL C, HOPFENGARTNER R et al. Magnetoencephalography in extratemporal epilepsy. J Clin Neurophysiol 2000;17:190-200.
27. FARMER JP, COSGROVE GR, VILLEMURE JG, MEAGHER-VILLEMURE K, TAMPIERI D, MELANSON D. Intracerebral cavernous angiomas. Neurology 1988;38:1699-704.
28. RIGAMONTI D, DRAYER BP, JOHNSON PC et al. appearance of cavernous malformations (angiomas). J Neurosurg 1987;67:518-24.
29. CASAZZA M, BROGGI G, FRANZINI A et al. Supratentorial cavernous angiomas and epileptic seizures: preoperative course and postoperative outcome. Neurosurgery 1996;39:26-32. discussion 32-4.
30. CASEY AT, THOMAS DG, HARKNESS WF. Stereotactically-guided craniotomy for cavernous angiomas presenting wit epilepsy. Acta Neurochir (Wien) 1995;137:34-7.
31. AWAD IA, ROBINSON JR JR, MOHANTY S, ESTES ML. Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery 1993;33:179-88. discussion 188.
32. HAYMAN LA, EVANS RA, FERRELL RE, FAHR LM, OSTROW P, RICCARDI VM. Familial cavernous angiomas: natural history and genetic study over a 5-year period. Am J Med Genet 1982;11:147-60.
33. KONDZIOLKA D, LUNSFORD LD, KESTLE JR. The natural history of cerebral cavernous malformations. J Neurosurg 1995;83:820-4.
34. LOBATO RD, PEREZ C, RIVAS JJ, CORDOBES F. Clinical, radiological, and pathological spectrum of angiographically occult intracranial vascular malformations. Analysis of 21 cases and review of the literature. J Neurosurg 1988;68:518-31.
35. MORIARITY JL, WETZEL M, CLATTERBUCK RE et al. The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery 1999;44:1166-71. discussion 1172-3.
36. MARAIRE JN, AWAD IA. Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery 1995;37:591-605.
37. CHURCHYARD A, KHANGURE M, GRAINGER K. Cerebral cavernous angioma: a potentially benign condition? Successful treatment in 16 cases. J Neurol Neurosurg Psychiatry 1992;55:1040-5.
38. ARITA K, KURISU K, IIDA K et al. Surgical treatment for intractable epilepsy caused by cavernous angioma in the temporal lobe of the dominant hemisphere-three case reports. Neurol Med Chir (Tokyo) 2000;40:439-45.
39. BRAUN V, ANTONIADIS G, RATH S, RICHTER HP. [Cavernoma. Indications for surgical removal and outcome]. Nervenarzt 1996;67:301-5.
40. CAPPABIANCA P, ALFIERI A, MAIURI F, MARINIELLO G, CIRILLO S, DE DIVITIIS E. Supratentorial cavernous malformations and epilepsy: seizure outcome after lesionectomy on a series of 35 patients. Clin Neurol Neurosurg 1997;99:179-83.
41. OJEMANN RG, OGILVY CS. Microsurgical treatment of supratentorial cavernous malformations. Neurosurg Clin N Am 1999;10:433-40.
42. SCHROEDER HW, GAAB MR, RUNGE U. Supratentorial cavernous angiomas and epileptic seizures: preoperative course and postoperative outcome. Neurosurgery 1997;40:885.
43. XIE J, MA Z, Luo S. [The clinical features and treatment of cerebral cavernous angiomas in children]. Zhonghua Yi Xue Za Zhi 2002;82:407-9.
44. CASAZZA M, AVANZINI G, CICERI E, SPREAFICO R, BROGGI G. Lesionectomy in epileptogenic temporal lobe lesions: preoperative seizure course and postoperative outcome. Acta Neurochir Suppl (Wien) 1997;68:64-9.
45. COSGROVE GR. Occult vascular malformations and seizures. Neurosurg Clin N Am 1999;10:527-35.
46. ZEVGARIDIS D, VAN VELTHOVEN V, EBELING U, REULEN HJ. Seizure control following surgery in supratentorial cavernous malformations: a retrospective study in 77 patients. Acta Neurochir (Wien) 1996;138:672-7.
47. CHABERT E, MORANDI X, CARNEY MP, RIAUD L, LOUAIL C, CARSIN-NICOL B. Intramedullary cavernous malformations. J Neuroradiol 1999;26:262-8.
48. STEFAN H, SCHELER G, HUMMEL C et al. Magentencephalography (MEG) predicts focal epileptogenicity in cavernomas. J Neurol, Neurosurg Psychiatry 2004; in press.
49. SZELIES B, SOBESKY J, PAWLIK G et al. Impaired benzodiazepine receptor binding in peri-lesional cortex of patients with symptomatic elipepsies studied by [(11)C]-flumazenil PET. Eur J Neurol 2002;9:137-42.